Edition:
India

Melinta Therapeutics, Inc. (MLNT.OQ)

MLNT.OQ on NASDAQ Stock Exchange Global Select Market

14.90USD
2:29am IST
Change (% chg)

$-1.15 (-7.17%)
Prev Close
$16.05
Open
$16.05
Day's High
$16.17
Day's Low
$14.30
Volume
84,424
Avg. Vol
38,918
52-wk High
$24.25
52-wk Low
$10.50

Select another date:

Wed, Jan 10 2018

BRIEF-Melinta Therapeutics Files For Resale Of Up To 6.9 Mln Shares By Selling Stockholders

* MELINTA THERAPEUTICS INC FILES FOR RESALE OF UP TO 6.9 MILLION SHARES OF CO'S COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING‍​ Source text: (http://bit.ly/2EqugN6) Further company coverage:

BRIEF-Melinta Therapeutics Files For Resale Of Up To 3.3 Mln Shares By Selling Stockholder

* MELINTA THERAPEUTICS INC FILES FOR RESALE OF UP TO 3.3 MILLION SHARES OF CO'S COMMON STOCK BY SELLING STOCKHOLDER - SEC FILING Source text for Eikon: (http://bit.ly/2CO48LP) Further company coverage:

BRIEF-Deerfield Management Reports 10 Pct Passive Stake In Melinta Therapeutics

* DEERFIELD MANAGEMENT COMPANY LP REPORTS A 10 PCT PASSIVE STAKE IN MELINTA THERAPEUTICS INC AS OF JAN 5 - SEC FILING Source text for Eikon: (http://bit.ly/2Eqi9zA) Further company coverage:

BRIEF-Medicines Company Announces Definitive Agreement To Sell Its Infectious Disease Business Unit To Melinta Therapeutics

* THE MEDICINES COMPANY ANNOUNCES DEFINITIVE AGREEMENT TO SELL ITS INFECTIOUS DISEASE BUSINESS UNIT TO MELINTA THERAPEUTICS

BRIEF-Melinta Therapeutics Enters Agreement To Acquire Infectious Disease Business From The Medicines Company

* MELINTA THERAPEUTICS ENTERS INTO AGREEMENT TO ACQUIRE INFECTIOUS DISEASE BUSINESS FROM THE MEDICINES COMPANY Source text for Eikon: Further company coverage:

Select another date: